Carbon fiber offers numerous material benefits including reduced wear, high strength-to-weight ratio, a similar elastic modulus to that of bone, and high biocompatibility. Carbon fiber implants are increasingly used in multiple arenas within orthopaedic surgery, including spine, trauma, arthroplasty, and oncology. In the orthopaedic oncologic population, the radiolucency of carbon fiber facilitates post-operative imaging for tumor surveillance or recurrence, the monitoring of bony healing and union, and radiation mapping and delivery.
When employed in composite materials within the medical domain, carbon fiber is typically combined with several types of resin matrices, one of the most common of which is carbon fiber–polyether ether ketone (CF–PEEK). There are numerous properties of carbon fiber that make it ideal for orthopaedic applications. It is highly biocompatible and chemically inert [2][3], generating no cellular toxicity in in vitro studies [3][4] and only a non-specific foreign body reaction in animal studies [4][5]. Its elastic modulus, a measure of resistance to deformity under stress, is close to that of bone, an important advantage over other implant materials [5][6]. The estimated elastic modulus of carbon fiber is 3.5 gigapascals (GPa); cortical bone has an elastic modulus of 12–20 GPa and cancellous bone 1 GPa. By contrast, the elastic modulus of stainless steel is 230 GPa and titanium ranges from 106–155 GPa [6][7][8][7,8,9]. The similar elastic modulus of carbon fiber implants to bone helps to lessen stress concentration at the bone–implant interface [9][10][10,11], though it is important to note that additional studies are needed to better validate whether this allows for improved healing potential, or may simply translate to insufficient stiffness for healing in certain unstable fracture types in the trauma setting [11][12][12,13]. Importantly, in this regard, the modulus of carbon fiber can be adjusted in manufacturing to match either cortical or cancellous bone [13][14].
The ability to withstand fatigue strain is yet another benefit of carbon fiber implants. Traditional implants demonstrate higher failure rates, especially in pathologic fractures, often due to non-union or hardware failure [14][15]. By contrast, CF–PEEK demonstrates the ability to withstand high strain loading, up to one million loading cycles, without evidence of failure [15][16]. The interface wear characteristics of carbon fiber are similarly encouraging. One study simulating a total hip arthroplasty investigated the wear results of a ceramic head on a CF–PEEK cup, and demonstrated a volumetric wear rate of 0.3 mm3/Mc (million cycles), lower than that of ceramic on cross-linked, ultra-high-molecular-weight polyethylene (UHMWPE), metal on cross-linked UHMWPE, or ceramic or metal on conventional UHMWPE [16][17]. This is particularly important when considering potential toxicity or allergic reactions from wear particles [17][18][18,19]. As a relatively more recent material used in the orthopaedic setting, there are relatively fewer large, long-term studies concerning carbon fiber implants compared to their metallic counterparts, but their durability has appeared promising thus far in the literature [19][20]. One of the most important advantages of carbon fiber implants over metallic implants is their radiolucency. On both magnetic resonance imaging (MRI) and computed tomography (CT), carbon fiber has minimal scatter or susceptibility artifact, respectively [20][21]. This radiolucency allows for improved post-operative monitoring of fracture healing and surveillance for local disease recurrence or progression in the orthopaedic oncologic population. In a comparative study comparing MRI signal loss in patients with femoral or tibial CF–PEEK or titanium implants, CF–PEEK implants demonstrated substantially less signal loss and MRI susceptibility artifact than titanium nails. Visualization scores, as graded by a musculoskeletal radiologist, were significantly higher in the CF–PEEK group across all MRI sequences, including T1-weighted, short tau inversion recovery (STIR), and contrast-enhanced, T1-weighted, fat-saturated sequences [20][21]. Additionally, many orthopaedic oncology patients require post-operative radiotherapy. The artifact generated by conventional metallic implants often interferes not only with mapping for radiation planning, but also with accurate dose calculation and delivery [21][22][23][22,23,24].